As a universally applicable gelling agent, thickener and stabilizer, pectin has become an indispensable component in many products from the food, cosmetic and pharmaceutical industries.

In spite of the COVID-19 pandemic and all related obstacles GEA could sign another contract for the engineering and supply of an electrostatic tar precipitator with a long-term customer.

GEA increase the maximum top speeds for several of its reciprocating and screw compressors.

Brazilian dairy farm “Fazenda Trevisan” produces and processes their own milk directly for the region; this end-to-end solution is possible thanks to sustainable GEA technology.

Seven model sizes with 25 capacity stages: With the new LG range (LG = Low GWP), which has been specially designed for use with low-GWP HFO refrigerants, the refrigeration and air-conditioning specialist GEA Bock will in future offer a semi-hermetic compressor portfolio with suitable compressor technology for all synthetic refrigerants.

A comprehensive suite of digitally enhanced Remote Service options heralds a new era of communication, interactive dialogue and immersive virtual reality experiences for GEA’s pharmaceutical clients.

Field tests demonstrate precision and reliability of GEA DairyMilk M6850 Cell Count Sensor.

With the delivery of a state-of-the-art and individually adapted wet scrubber plant, GEA supports its customer Licharz, a specialized manufacturer of semi-finished engineering plastics, in its goal to reduce environmental impact.

GEA Group AG decided on strategic guidelines and significant investments to further optimize its production network. In this context, production at the Bodenheim site near Mainz will be discontinued by the end of 2024. The plant in Koszalin, Poland, will be expanded into a Center of Competence for pump production and comprehensive machining. GEA will invest around EUR 30 million in this expansion. Investments and a further consolidation of production and process activities are planned at other locations, too. The aim is to further strengthen GEA’s global production network in order to increase productivity and reduce its cost base.

"PROTINUS" (lat. forward, further") is the name of the project with which the biopharmaceutical company CSL Behring will significantly increase the production capacity of immunoglobulin at its site. GEA received the order for the process plant, the heart of the facility.